Immunitybio Inc (IBRX) stock has gained 207.60% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives IBRX stock a score of 55 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 88. IBRX's rank also includes a short-term technical score of 75.
IBRX has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on IBRX!
Immunitybio Inc (IBRX) stock is lower by -3.4% while the S&P 500 has gained 0.28% as of 11:35 AM on Tuesday, Mar 26. IBRX is lower by -$0.18 from the previous closing price of $5.44 on volume of 1,030,729 shares. Over the past year the S&P 500 has gained 31.56% while IBRX has gained 207.60%. IBRX lost -$1.15 per share in the over the last 12 months.
Click Here to get the full Stock Report for Immunitybio Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
